Specifically, Ginsberg and colleagues [141] have found that, in individuals with AD, downregulation of BDNF is associated with increased APs in the entorhinal cortex, and downregulation of TrkB is associated with increased NFTs in the entorhinal cortex and APs in the hippocampus. Here, NTRK2 is linked to Alzheimer disease.